Interleukin-6 level is an independent predictor of right ventricular systolic dysfunction in patients hospitalized with COVID-19

Creative Commons License

Erdogan M., Kalem A. K., Ozturk S., Erdol M. A., Kayaaslan B., Ozbebek Y. E., ...Daha Fazla

ANATOLIAN JOURNAL OF CARDIOLOGY, cilt.25, sa.8, ss.555-565, 2021 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 25 Sayı: 8
  • Basım Tarihi: 2021
  • Doi Numarası: 10.5152/anatoljcardiol.2021.24946
  • Dergi Adı: ANATOLIAN JOURNAL OF CARDIOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CINAHL, EMBASE, MEDLINE, Directory of Open Access Journals, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.555-565
  • Anahtar Kelimeler: coronavirus disease 2019, interleukin-6, transthoracic echocardiography, right ventricle, EUROPEAN ASSOCIATION, MYOCARDIAL INJURY, AMERICAN SOCIETY, ECHOCARDIOGRAPHY, ADULTS, WUHAN, IL-6
  • Yozgat Bozok Üniversitesi Adresli: Hayır

Özet

Objective: Cytokine storm with elevated levels of multiple proinflammatory cytokines and inflammatory system activation underlie the pathogenesis of coronavirus disease 2019 (COVID-19). In this study, we aimed to investigate whether increased interleukin (IL)-6 levels can predict right ventricular (RV) systolic impairment in patients hospitalized with COVID-19.